- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02874781
Microcirculation of Patients With Kidney Transplant
December 12, 2016 updated by: National Taiwan University Hospital
Sublingual Microcirculation Data of Patients With Kidney Transplant
This study measures the sublingual microcirculation of patients with kidney transplant using MicroScan.
The data will be compared with data of health volunteers and end stage renal disease patients on hemodialysis.
Study Overview
Status
Completed
Conditions
Detailed Description
This study measures the sublingual microcirculation of patients with kidney transplant using MicroScan.
The data will be compared with data of health volunteers and end stage renal disease patients on hemodialysis.
The microcirculation date includes total small vessel density, perfused small vessel density, proportion of perfused vessels, microvascular flow index, and heterogeneity index.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 79 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with kidney transplant
Description
Inclusion Criteria:
- patients with kidney transplant for more than one month
Exclusion Criteria:
- Body mass index (BMI) < 18.5 or > 30
- diagnosis of sepsis or trauma, or admitted to intensive care unit within one month before enrollment
- body temperature < 35.5 or > 37.5 Celsius
- patients with tongue resection
- non-native speaker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Total small vessel density
Time Frame: 6 hours
|
6 hours
|
|
Perfused small vessel density
Time Frame: 6 hours
|
6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
August 5, 2016
First Submitted That Met QC Criteria
August 19, 2016
First Posted (Estimate)
August 22, 2016
Study Record Updates
Last Update Posted (Estimate)
December 14, 2016
Last Update Submitted That Met QC Criteria
December 12, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 201605035RINC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.